keyword
https://read.qxmd.com/read/38652480/navigating-the-tumor-microenvironment-mesenchymal-stem-cell-mediated-delivery-of-anticancer-agents
#1
REVIEW
Muhammad Ahsan Waqar, Muhammad Zaman, Muhammad ShafeeqUrRahman, Rabeel Khan, Imtiaz Majeed
Scientific knowledge of cancer has advanced greatly throughout the years, with most recent studies findings includes many hallmarks that capture disease's multifaceted character. One of the novel approach utilized for the delivery of anti-cancer agents includes mesenchymal stem cell mediated drug delivery. Mesenchymal stem cells (MSCs) are non-hematopoietic progenitor cells that may be extracted from bone marrow, tooth pulp, adipose tissue and placenta/umbilical cord blood dealing with adult stem cells. MSCs are mostly involved in regeneration of tissue, they have also been shown to preferentially migrate to location of several types of tumor in-vivo ...
April 23, 2024: Journal of Drug Targeting
https://read.qxmd.com/read/38652158/development-and-validation-of-models-for-predicting-mortality-in-intertrochanteric-fracture-surgery-patients-with-perioperative-blood-transfusion-a-prospective-multicenter-cohort-study
#2
JOURNAL ARTICLE
Junfei Guo, Qian Geng, Ke Xu, Wensen Jing, Zheng Li, Jinwen He, Ying Pan, Yanan Li, Tao Wang, Yubin Long, Zhiyong Hou, Xin Xu, Peng Xu
BACKGROUND: The association between allogenic blood transfusions (ABT) and all-cause mortality in surgically treated hip fracture patients with perioperative transfusion (STHFPT) remained unknown. We aim to introduce transfusion-related factors, new variables to develop and validate models to predict mortality in these patients. METHODS: A prospective multicenter cohort study was conducted with STHFPT hospitalized during Jan. 2018 and Jun. 2021. The database was divided into training cohort and validation cohort in a ratio of 70% to 30% using the randomization method...
April 23, 2024: International Journal of Surgery
https://read.qxmd.com/read/38652075/unveiling-the-uncommon-a-unique-case-of-alps-like-syndrome-complicated-by-plasma-cell-disorder
#3
JOURNAL ARTICLE
Meziane Brizini, Bruno Michon, Marc-Antoine Bédard
Multiple myeloma is a rare disease in pediatrics, where about 30 cases are described under 15 years old. It is even rarer when atypical multiple myeloma occurs in the context of autoimmunity. This case describes a 9-year-old female with autoimmune lymphoproliferative-like disease and combined immune deficiency that developed acute kidney failure with monoclonal peak associated with RAC2 and TNFRSF9 variants. An adapted protocol from the backbone adult multiple myeloma standard of care with the addition of an allogeneic hematopoietic stem cell transplant was used...
April 23, 2024: Journal of Pediatric Hematology/oncology
https://read.qxmd.com/read/38652069/variable-clinical-courses-of-varicella-zoster-virus-infection-related-or-vaccination-related-bone-marrow-failure
#4
JOURNAL ARTICLE
Vasil Toskov, Annamaria Cseh, Alexander Claviez, Beatrice Drexler, Natalia Rotari, Stephan Schwarz-Furlan, Matthias Braun, Peter Bader, Peter Lang, Rita Beier, Bernhard Erdlenbruch, Monika Führer, Miriam Erlacher, Charlotte M Niemeyer, Brigitte Strahm, Ayami Yoshimi
We report 5 children with bone marrow failure (BMF) after primary varicella zoster virus (VZV) infection or VZV vaccination, highlighting the highly variable course. Two patients were treated with intravenous immunoglobulins; one had a slow hematologic recovery, and the other was rescued by allogeneic hematopoietic stem cell transplantation (HSCT). Of the 2 patients treated with immunosuppressive therapy with antithymocyte globulin and cyclosporine, one had a complete response, and the other was transplanted for nonresponse...
April 23, 2024: Journal of Pediatric Hematology/oncology
https://read.qxmd.com/read/38651865/tandem-autologous-hematopoietic-stem-cell-transplantation-for-patients-with-multiple-myeloma-a-systematic-review-and-meta-analysis
#5
REVIEW
Hongtao Li, Yaxin Zheng, Kehai Gao, Chen Tian
To evaluate whether patients with multiple myeloma (MM) could benefit from tandem autologous hematopoietic stem cell transplantation (auto-HSCT), PubMed, Embase, Web of Science and Cochrane Library databases were systematically searched, and 10 eligible studies were included after data extraction and quality evaluation. Meta-analysis showed that compared to single autologous hematopoietic stem cell transplantation, tandem auto-HSCT does not improve OS, EFS or efficacy in MM patients, and may even lead to higher treatment-related mortality (TRM)...
December 2024: Hematology (Amsterdam, Netherlands)
https://read.qxmd.com/read/38651452/post-transplant-cyclophosphamide-versus-anti-thymocyte-globulin-in-patients-with-hematological-malignancies-treated-with-allogeneic-hematopoietic-stem-cell-transplantation-from-haploidentical-and-matched-unrelated-donors-a-real-life-experience
#6
JOURNAL ARTICLE
Bianca Serio, Gabriella Storti, Matteo D'Addona, Lidia Santoro, Camilla Frieri, Danilo De Novellis, Luana Marano, Giovanna De Santis, Roberto Guariglia, Ilenia Manfra, Eleonora Urciuoli, Serena Luponio, Serena Marotta, Denise Morini, Michela Rizzo, Fausto Palmieri, Nicola Cantore, Valentina Giudice, Antonio Maria Risitano, Carmine Selleri
Background: Post-transplant cyclophosphamide (PTCY) is widely used as graft versus host disease (GvHD) prophylaxis in allogeneic hematopoietic stem cell transplant (HSCT) recipients, with reported clinical benefits in patients who underwent transplant from a matched unrelated donor (MUD). However, real-life data on clinical efficacy and safety of PTCY in haploidentical and MUD transplantations are still poor. Methods: In our real-life retrospective observational study, we included a total of 40 consecutive adult patients who underwent haploidentical or MUD HSCT for various hematological malignancies and who received PTCY ( n = 24) or ATG ( n = 16) as GvHD prophylaxis at Hematology Units from hospitals of Salerno and Avellino, Italy, and clinical outcomes were compared...
April 17, 2024: Hematology Reports
https://read.qxmd.com/read/38650946/innovations-in-bio-engineering-and-cell-based-approaches-to-address-immunological-challenges-in-islet-transplantation
#7
REVIEW
Beatrice Xuan Ho, Adrian Kee Keong Teo, Natasha Hui Jin Ng
Human allogeneic pancreatic islet transplantation is a life-changing treatment for patients with severe Type 1 Diabetes (T1D) who suffer from hypoglycemia unawareness and high risk of severe hypoglycemia. However, intensive immunosuppression is required to prevent immune rejection of the graft, that may in turn lead to undesirable side effects such as toxicity to the islet cells, kidney toxicity, occurrence of opportunistic infections, and malignancies. The shortage of cadaveric human islet donors further limits islet transplantation as a treatment option for widespread adoption...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38650933/eltrombopag-can-promote-platelet-implantation-after-allogeneic-hematopoietic-stem-cell-transplantation-as-safely-and-similarly-to-thrombopoietin
#8
JOURNAL ARTICLE
Yahan Li, Fansheng Kong, Guanchen Bai, Yujie Jiang, Wenlu Zhang, Xue Sun, Xiaohui Sui, Ying Li, Mei Ding, Dai Yuan, Xin Wang, Xiaosheng Fang
BACKGROUND: Eltrombopag has demonstrated efficacy in treating low platelet (PLT) levels, but it remains unclear whether eltrombopag can promote PLT engraftment after hematopoietic stem cell transplantation (HSCT). METHODS: Forty-one HSCT patients received eltrombopag 50 mg/d from +1 day until PLT >50 × 109 /L or 1 month after HSCT. Fifty-one patients in the same period received thrombopoietin (TPO) to promote PLT graft after HSCT and served as a control group...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38650748/efficacy-of-allogeneic-tendon-material-coracoclavicular-ligament-reconstruction-combined-with-kirschner-wire-and-titanium-alloy-hook-plate-material-fixation-in-the-treatment-of-acromioclavicular-joint-dislocation
#9
JOURNAL ARTICLE
Bing Du, Yibo Xu, Zhao Li, Shuai Ji, Cheng Ren, Ming Li, Kun Zhang, Teng Ma
OBJECTIVE: To compare the effects of allogeneic tendon coracoclavicular ligament reconstruction combined with Kirschner wire fixation and clavicular hook plate fixation on early postoperative pain, postoperative shoulder joint function score and shoulder joint mobility in patients with acromioclavicular joint dislocation. METHODS: From January 2020 to January 2023, 43 patients with acromioclavicular joint dislocation admitted to Xi 'an Honghui Hospital were included...
2024: Frontiers in Bioengineering and Biotechnology
https://read.qxmd.com/read/38648898/treosulfan-versus-busulfan-based-conditioning-in-allogeneic-hematopoietic-cell-transplantation-for-myelodysplastic-syndrome-a-single-center-retrospective-propensity-score-matched-cohort-study
#10
JOURNAL ARTICLE
Ivan Pasic, Tommy Alfaro Moya, Mats Remberger, Carol Chen, Armin Gerbitz, Dennis Dong Hwan Kim, Rajat Kumar, Wilson Lam, Arjun Datt Law, Jeffrey H Lipton, Fotios V Michelis, Igor Novitzky-Basso, Auro Viswabandya, Jonas Mattsson
Treosulfan has shown promise in allogeneic hematopoietic cell transplantation (HCT) for its myeloablative properties and low toxicity. In this single-center retrospective propensity score-matched cohort study we compared treosulfan- and busulfan-based conditioning in allogeneic HCT for patients with myelodysplastic syndrome (MDS). This study included 138 adults who underwent allogeneic HCT for MDS or chronic myelomonocytic leukemia (CMML) at Princess Margaret Hospital, Toronto 2015-2022. Using propensity score matching, we compared transplant outcomes between two well-matched cohorts who received conditioning with either fludarabine-treosulfan (FT) (n=46) or fludarabine-busulfan with total body irradiation (FBT200) (n=92)...
April 20, 2024: Transplantation and cellular therapy
https://read.qxmd.com/read/38648559/cost-effectiveness-of-adding-quizartinib-to-induction-chemotherapy-for-patients-with-flt3-mutant-acute-myeloid-leukemia
#11
JOURNAL ARTICLE
Jan Philipp Bewersdorf, Kishan K Patel, Rory M Shallis, Nikolai A Podoltsev, Tariq Kewan, Jessica Stempel, Lourdes Mendez, Maximilian Stahl, Eytan M Stein, Scott F Huntington, George Goshua, Amer M Zeidan
The FLT3 inhibitor quizartinib has been shown to improve overall survival when added to intensive induction chemotherapy ("7 + 3") in patients 18-75 years old with newly diagnosed AML harboring a FLT3- ITD mutation. However, the health economic implications of this approval are unknown. We evaluated the cost-effectiveness of quizartinib using a partitioned survival analysis model. One-way and probabilistic sensitivity analyses were conducted. In the base case scenario, the addition of quizartinib to 7 + 3 resulted in incremental costs of $289,932 compared with 7 + 3 alone...
April 22, 2024: Leukemia & Lymphoma
https://read.qxmd.com/read/38648544/blood-derived-eye-drops-for-the-treatment-of-corneal-neuropathic-pain
#12
JOURNAL ARTICLE
Ansa Anam, Chang Liu, Louis Tong, Yu-Chi Liu
Blood-derived preparations, including autologous or allogenic serum, umbilical cord serum/plasma, and platelet-rich plasma eye drops, contain various growth factors, cytokines, and immunoglobulins that resemble natural tears. These components play important roles in corneal cell migration, proliferation, and wound healing. Blood-derived eye drops have demonstrated clinical effectiveness across a spectrum of ocular surface conditions, encompassing dry eye disease, Sjögren's syndrome, graft-versus-host disease, and neuropathic corneal pain (NCP)...
April 22, 2024: Journal of Ocular Pharmacology and Therapeutics
https://read.qxmd.com/read/38648067/anti-tumor-activity-of-a-novel-lair1-antagonist-in-combination-with-anti-pd-1-to-treat-collagen-rich-solid-tumors
#13
JOURNAL ARTICLE
B Leticia Rodriguez, Jiawei Huang, Laura Gibson, Jared J Fradette, Hung-I H Chen, Kikuye Koyano, Czrina Cortez, Betty Li, Carmence Ho, Amir M Ashique, Vicky Y Lin, Suzanne Crawley, Julie M Roda, Peirong Chen, Bin Fan, Jeong Kim, James Sissons, Jonathan Sitrin, Daniel D Kaplan, Don L Gibbons, Lee B Rivera
We recently reported that resistance to PD-1-blockade in a refractory lung cancer-derived model involved increased collagen deposition and the collagen-binding inhibitory receptor leukocyte-associated immunoglobulin-like receptor 1 (LAIR1), and thus we hypothesized that LAIR1 and collagen cooperated to suppress therapeutic response. Here, we report LAIR1 is associated with tumor stroma and is highly expressed by intratumoral myeloid cells in both human tumors and mouse models of cancer. Stroma-associated myeloid cells exhibit a suppressive phenotype and correlate with LAIR1 expression in human cancer...
April 22, 2024: Molecular Cancer Therapeutics
https://read.qxmd.com/read/38647278/uncommon-bk-polyomaviruses-detected-in-allogeneic-hematopoietic-cell-transplant-recipients
#14
JOURNAL ARTICLE
Saagar M Chokshi, Elizabeth A Odegard, Heidi L Meeds, Steven B Kleiboeker, Assem Ziady, Anthony Sabulski, Sonata Jodele, Alix E Seif, Stella M Davies, Benjamin L Laskin, Jason T Blackard
The role of viral diversity in the pathogenesis of BK polyomavirus (BKPyV)-associated disease is poorly understood. Here, we report near full-length BKPyV genome sequences from two allogeneic hematopoietic cell transplant recipients infected with BKPyV genotype II, which is uncommon in the USA.
April 22, 2024: Microbiology Resource Announcements
https://read.qxmd.com/read/38647100/effect-of-geography-on-the-use-of-ultrafiltration-during-cardiac-surgery-with-cardiopulmonary-bypass
#15
JOURNAL ARTICLE
Kirti P Patel, Alfred H Stammers, Eric A Tesdahl, Jeffrey Chores, Scott R Beckmann, Jennifer Baeza, Craig M Petterson, Ty Thompson, Alexander Baginski, Michael Firstenberg, Jeffrey P Jacobs
BACKGROUND: Ultrafiltration (UF) is a common practice during cardiopulmonary bypass (CPB) where it is used as a blood management strategy to reduce red blood cell (RBC) transfusion, minimize adverse effects of hemodilution, and reduce proinflammatory mediators. However, its clinical utilization has been shown to vary throughout the continents. PURPOSE: The purpose of this investigation was to assess the distribution of UF use across the United States. DATA COLLECTION: Data on UF use during cardiac surgery was obtained from a national (United States) perfusion database for adult cardiac procedures performed from January 2016 through December 2018...
April 22, 2024: Perfusion
https://read.qxmd.com/read/38646694/treatment-of-an-infrabony-defect-of-a-maxillary-canine-tooth-using-enamel-matrix-derivatives-with-allogeneic-bone-augmentation-in-a-dog
#16
JOURNAL ARTICLE
Se Eun Kim, Gahyun Lee
A 5-year-old Miniature Dachshund was presented having an infrabony pocket on the palatal aspect of the right maxillary canine tooth. The bony defect had worsened despite previous closed root planing and administration of a perioceutic agent. A second surgery using an allogeneic cancellous bone augmentation with an enamel matrix derivative was performed in the infrabony defect following open root planing. Eight months after the periodontal surgery, the osseous defect showed healing by improved periodontal probing measurements and increased radiopacity using dental radiography and computed tomography...
April 22, 2024: Journal of Veterinary Dentistry
https://read.qxmd.com/read/38646536/the-state-of-the-art-in-the-treatment-of-severe-aplastic-anemia-immunotherapy-and-hematopoietic-cell-transplantation-in-children-and-adults
#17
REVIEW
Agnieszka Piekarska, Katarzyna Pawelec, Anna Szmigielska-Kapłon, Marek Ussowicz
Acquired aplastic anemia (AA) is an immune-mediated bone marrow (BM) failure where marrow disruption is driven by a cytotoxic T-cell-mediated autoimmune attack against hematopoietic stem cells. The key diagnostic challenge in children, but also in adults, is to exclude the possible underlying congenital condition and myelodysplasia. The choice of treatment options, either allogeneic hematopoietic cell transplantation (alloHCT) or immunosuppressive therapy (IST), depends on the patient's age, comorbidities, and access to a suitable donor and effective therapeutic agents...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38646173/allogeneic-platelet-rich-plasma-for-knee-osteoarthritis-in-patients-with-primary-immune-thrombocytopenia-a-randomized-clinical-trial
#18
JOURNAL ARTICLE
Xiaohang Zhu, Lingying Zhao, Nicoletta Riva, Ziqiang Yu, Miao Jiang, Feng Zhou, Alexander Gatt, Peter V Giannoudis, Jiong Jiong Guo
The treatment of painful KOA in adult patients with ITP has not been well studied yet. We conducted a prospective, double-blind, randomized, placebo-controlled trial to evaluate the efficacy of intra-articular allogeneic PRP injections on symptoms and joint structure in patients with KOA and ITP. 80 participants were randomly allocated in a 1:1 ratio to allogeneic PRP group or saline group. The primary outcome was the WOMAC total score at 12 months post-injection. The number of patients in each group who achieved MCID of primary outcome showed a statistically significant difference only at 3-month (27/39 vs...
May 17, 2024: IScience
https://read.qxmd.com/read/38645784/recent-advancements-in-hematopoietic-stem-cell-transplantation-in-taiwan
#19
REVIEW
Chi-Cheng Li, Xavier Cheng-Hong Tsai, Wei-Han Huang, Tso-Fu Wang
Hematopoietic stem cell transplantation (HSCT) can cure malignant and nonmalignant hematological disorders. From 1983 to 2022, Taiwan performed more than 10,000 HSCT transplants. The Taiwan Blood and Marrow Transplantation Registry collects clinical information to gather everyone's experience and promote the advances of HSCT in Taiwan to gather everyone's experience and promote advances of HSCT in Taiwan. Compared with matched sibling donors, transplants from matched unrelated donors exhibited a trend of superior survival...
2024: Tzu chi medical journal
https://read.qxmd.com/read/38644613/car-t-from-cord-blood-in-a-patient-with-ph-acute-lymphoblastic-leukemia-relapsing-after-hematopoietic-stem-cell-transplantation
#20
John Donald Marra, Eugenio Galli, Sabrina Giammarco, Elisabetta Metafuni, Gessica Minnella, Federica Fosso, Sara Marietti, Simona Sica, Federica Sorà, Patrizia Chiusolo
While there is intense interest in the production of allogeneic CAR-T cells from umbilical cord units, little is known about the reactivity and persistence of CAR-T cells of umbilical origin. We report the case of a patient at our hematological center with multiple relapsing Ph+ B-ALL, notably a Blinatunomab non-responder, who underwent therapy with Brexucabtagene Autoleucel following relapse on Ponatinib post-allogeneic hematopoietic stem cell transplantation. The patient achieved a rapid CAR-T expansion and durable remission presenting in good clinical conditions 6 months post-CAR-T infusion, without manifestations of graft-versus-host disease...
April 21, 2024: European Journal of Haematology
keyword
keyword
9611
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.